보고서 요약(국문)

개요
글로벌 소아 신경과 의료기기 시장은 2022년 XX백만 달러에 도달했으며, 2023년부터 2030년까지 연평균 성장률(CAGR) XX%로 성장하여 2030년에는 XX백만 달러에 이를 것으로 예상됩니다.
소아 신경과 의료기기는 소아의 신경 질환 진단, 치료 및 관리에 중요한 역할을 합니다. 이러한 기기들은 청소년 환자의 특수한 의료적 요구 사항을 충족하도록 특별히 개발되었습니다. 소아 신경과에서 사용되는 기기들은 소아의 신경 문제를 정확하고 신속하게 식별할 수 있도록 해줍니다. 효과적인 치료와 소아 환자의 삶의 질 향상은 조기 진단에 달려 있습니다.
신경 문제를 지속적으로 관리하고 모니터링하는 것은 매우 중요합니다. 뇌파 검사(EEG) 장비 및 기타 소아 신경과 기기들은 뇌 활동을 모니터링하여 의료 전문가가 필요에 따라 치료 계획을 조정할 수 있도록 도와줍니다. 소아 신경과 전문의들은 최상의 치료를 제공하기 위해 이러한 기기들을 활용합니다. 이러한 자료들은 의료 전문가들이 이용 가능한 치료법에 대해 충분한 정보를 바탕으로 선택할 수 있도록 도와주며, 아이들이 각자의 고유한 질환에 맞는 최상의 치료를 받을 수 있도록 보장합니다.
시장 동향: 동인 및 제약 요인
기업들이 채택한 전략
기술 발전으로 소아 환자에게 더욱 작고 정확하며 효과적인 기기를 생산할 수 있게 되었습니다. 이러한 발전에는 소형화, 향상된 센서 및 새로운 구성 요소가 포함됩니다. 이러한 개발을 통해 소아 신경과 기기의 효과와 안전성이 향상되었습니다. 또한, 기업들의 신제품 출시는 시장 확장을 가속화하는 데 도움이 됩니다.
예를 들어, 2022년 10월, NeuroSigma의 Monarch 외부 삼차신경 자극(eTNS) 시스템은 현재 약물 치료를 받지 않는 7~12세 주의력 결핍 과잉 행동 장애(ADHD) 환자 치료에 사용할 수 있습니다. 중등도에서 중증 ADHD 아동 62명을 대상으로 한 위약 대조 임상 시험 결과를 바탕으로, 이 기기는 2019년 FDA 승인을 받았습니다.
또한, 2023년 3월 미니애폴리스의 한 병원은 미국 최초의 소아용 하이브리드 수술 중 MRI 신경외과 장비를 개설했습니다. 미네소타 아동병원의 신경과학 프로그램과 영상의학과에서는 2,970평방피트 규모의 리처드 M. 슐츠 가족 재단 iMRI 수술실을 활용하고 있습니다. 미니애폴리스 병원에서 뇌종양, 간질, 외상성 손상 등을 치료하는 수술 도중 전문의들은 뇌와 척추 전체 스캔을 시행합니다.
소아 신경 질환에 대한 인식이 높아지고 조기 진단의 중요성이 부각됨에 따라, 부모와 의료 전문가들은 더욱 향상된 진단 및 치료 옵션을 점점 더 많이 찾고 있습니다. 이러한 수요 증가는 혁신적인 소아 중심 의료 기술 개발을 촉진하고 있습니다. 자폐증, 뇌성마비 및 기타 소아 신경 질환은 전 세계적으로 점점 더 흔해지고 있습니다.
시장 동향: 제약 요인
소아 신경과 의료기기는 상당한 발전을 이루었지만, 여러 제약 요인으로 인해 개발, 도입 및 효과적인 사용이 어려워지고 있습니다. 예를 들어, 소아 의료기기 연구 개발에 대한 자금 및 투자 부족이 발전을 저해할 수 있습니다.
특수 기기의 작은 시장 규모와 높은 개발 비용은 투자자와 기업이 이 산업에 투자하는 것을 주저하게 만들 수 있습니다. 성인과 신체 및 생리적 반응이 다른 소아 환자에게 효율적이고 안전하게 사용할 수 있는 기기를 개발하는 데 기술적인 어려움이 발생합니다.
세분화 분석
전 세계 소아 신경과 의료기기 시장은 제품 유형, 적용 분야, 연령대, 최종 사용자 및 지역별로 세분화됩니다.

신경자극 장치 부문은 니만-픽병 유형 시장 점유율의 약 41.7%를 차지했습니다.
소아 신경학 분야에서는 다양한 신경 질환을 치료하고 신경 장애 아동의 삶의 질을 향상시키기 위해 신경자극 장치를 점점 더 많이 사용하고 있습니다. 이러한 장치는 특정 신경이나 뇌 영역에 전기 자극을 보내 다양한 질병과 관련된 비정상적인 신경 활동을 조절합니다. 이러한 장치의 특성과 기업의 기술력 덕분에 해당 부문의 성장이 가속화되고 있습니다.
예를 들어, 2023년 2월 2일, 리바노바(LivaNova PLC)는 약물 저항성 간질 관리를 위한 미주신경 자극 치료(VNS)를 제공하는 이중 핀 헤더가 있는 이식형 맥박 발생기(IPG)인 센티바 듀오(SenTiva DUO)를 출시했습니다. 부분 발작을 보이는 4세 이상의 소아 및 성인의 약물 저항성 간질에 대한 추가 치료법으로, VNS 치료는 과학적으로 안전하고 효과적인 것으로 입증되었습니다. 이는 약물 저항성 간질 환자를 위해 개발된 첨단 치료 방법으로, 간질 환자 3명 중 1명꼴로 이러한 질환을 앓고 있습니다. 따라서 이러한 모든 요인들이 해당 부문의 성장을 뒷받침하고 있습니다.
지역 분석
북미는 2022년 시장 점유율의 약 38.4%를 차지했습니다.
뇌성마비, 간질, 뇌졸중 및 기타 신경계 질환의 유병률 증가, 연구 개발 활동 확대, 투자 증가, 정부 지원 정책, 주요 시장 참여 기업들의 핵심 사업 추진 등이 북미 소아 신경과 의료기기 시장 성장을 견인하는 주요 요인입니다.
이 기간 동안 미국은 북미 시장에서 상당한 비중을 차지할 것으로 예상됩니다. 예를 들어, 2022년 3월 Congress.gov 자료에 따르면 미국에서는 매년 1만 명 이상의 영유아가 뇌성마비 진단을 받습니다. 미국 내 뇌성마비 발병률이 높기 때문에 이러한 의료기기에 대한 수요가 증가하고 있습니다. 따라서 이러한 모든 요소들이 지역 성장을 가속화하는 데 도움이 됩니다.
더욱이 아시아 태평양 지역은 상당한 성장을 보일 것으로 예상됩니다. 이는 중국과 인도처럼 인구가 많은 국가들이 많아 유전 질환을 앓는 사람이 더 많을 가능성이 높고, 시장 참여자들이 시행하는 전략과 트렌드가 증가하고 있기 때문입니다.
COVID-19 영향 분석
팬데믹 상황에서는 의료 서비스의 우선순위가 바뀔 수 있습니다. COVID-19 환자 유입 관리에 자원 재배치가 필요할 수 있으며, 이는 일부 소아 신경과 제품을 포함한 비필수 의료 기기에 대한 수요에 영향을 미칠 수 있습니다. 팬데믹은 종종 경기 침체기에 발생합니다. 예산 제약으로 인해 병원과 의료 시설은 새로운 의료 장비, 특히 소아 신경과 장비를 구매하지 못할 수 있습니다.
팬데믹 상황에서는 의료 기기의 공급 및 생산망이 심각하게 중단될 수 있습니다. 소아 신경과 장비의 공급은 운송 문제, 공장 폐쇄, 이동 제한 등으로 인해 영향을 받을 수 있습니다. 수많은 신경계 질환이 COVID-19와 관련되어 있습니다. 소아 환자의 경우 질병의 장기적인 영향 때문에 이러한 증상을 치료하기 위해 특수 신경과 장비가 필요할 수 있습니다.
시장 세분화
제품 유형별
• 신경 자극 장치
• 신경외과 장치
• 뇌척수액(CSF) 관리 장치
• 기타
적용 분야별
• 간질 진단 및 관리
• 뇌성마비 관리
• 자폐 스펙트럼 장애(ASD) 관리
• 유전성 신경 질환
• 기타
연령대별
• 영유아
• 미취학 아동
• 청소년
최종 사용자별
• 소아 병원
• 전문 클리닉
• 기타
지역별
• 북미
o 미국
o 캐나다
o 멕시코
• 유럽
o 독일
o 영국
o 프랑스
o 이탈리아
o 스페인
o 기타 유럽
• 남미
o 브라질
o 아르헨티나
o 기타 남미
• 아시아 태평양
o 중국
o 인도
o 일본
o 호주
o 기타 아시아 태평양
• 중동 및 아프리카
경쟁 환경
시장의 주요 글로벌 업체는 다음과 같습니다. Integra LifeSciences, Medtronic, Abbott Laboratories, B.Braun Melsungen, Philips Healthcare, LivaNova, Boston Scientific, Natus Medical, Masimo Corporation, Compumedics Limited 등이 있습니다.
주요 개발 사항
• 2023년 3월 21일, 미국 식품의약국(FDA)은 Inspire Medical Systems, Inc.에 다운증후군 소아 환자에게 Inspire 치료법을 제공할 수 있도록 승인했습니다. Inspire Medical Systems, Inc.는 폐쇄성 수면 무호흡증(OSA) 환자를 위한 혁신적이고 최소 침습적인 솔루션 개발 및 상용화에 주력하고 있습니다.

• 2023년 1월, Data360은 신경계 및 신경정신 질환 치료를 위한 외부 삼차신경 자극(eTNS) 기술을 판매하는 로스앤젤레스 소재 생체 전자 기업인 NeuroSigma, Inc.와 전략적 디지털 마케팅 협력을 시작했습니다. 이러한 계획은 인공지능(AI) 기반의 혁신적인 데이터 플랫폼을 제공하는 Data360과의 협력을 통해 지원될 것입니다.
보고서 구매 이유:

• 제품 유형, 적용 분야, 연령대, 최종 사용자 및 지역별 글로벌 소아 신경과 기기 시장 세분화를 시각화하고 주요 상업 자산 및 주요 업체를 파악합니다.

• 트렌드 분석 및 공동 개발을 통해 사업 기회를 발굴합니다.

• 모든 세그먼트를 포함한 소아 신경과 기기 시장 수준의 다양한 데이터가 담긴 Excel 데이터 시트를 제공합니다.

• 심층적인 질적 인터뷰와 연구를 바탕으로 종합적인 분석 결과를 담은 PDF 보고서를 제공합니다.

• 주요 업체들의 핵심 제품을 포함한 제품 맵핑 자료를 Excel 파일로 제공합니다.

글로벌 소아 신경과 기기 시장 보고서는 약 69개의 표, 58개의 그림, 187페이지로 구성됩니다.
대상 고객 (2023년 기준):
• 제조업체/구매자
• 산업 투자자/투자 은행가
• 연구 전문가
• 신흥 기업

보고서 요약(영어 원문)

Overview
Global Pediatric Neurology Devices Market reached US$ XX million in 2022 and is expected to reach US$ XX million by 2030, growing with a CAGR of XX % during the forecast period 2023-2030.
Pediatric neurology devices play a crucial role in the diagnosis, treatment, and management of neurological disorders in children. These devices have been specially created to cater to the particular medical requirements for adolescents patients. Devices used in pediatric neurology allow for the precise and rapid identification of neurological problems in children. Effective therapy and an increase in the quality of life for pediatric patients depend on early diagnosis.
It is frequently necessary to manage and continuously monitor neurological issues. EEG equipment (Electroencephalography) and other pediatric neurology gadgets aid in the monitoring of brain activity, allowing medical experts to modify treatment regimens as necessary. To deliver the best care possible, pediatric neurology specialists in the medical field rely on these devices. These resources help medical professionals make well-informed choices regarding available therapies, ensuring that kids get the best care possible for their unique conditions.
Market Dynamics: Drivers and Restraints
The strategies adopted by the companies
Technology advancements have made it possible to produce devices that are more compact, accurate, and effective for pediatric patients. These advancements include miniaturisation, enhanced sensors, and novel components. The effectiveness and safety of pediatric neurology devices are improved by these developments. Additionally, the launch of new products by companies aids in accelerating market expansion.
For instance, in October 2022, The Monarch external Trigeminal Nerve Stimulation (eTNS) System from NeuroSigma is currently available to treat patients with attention-deficit/hyperactivity disorder (ADHD) aged 7 to 12 who are not receiving medication for the condition. Based on findings from a placebo-controlled clinical trial including 62 kids with moderate to severe ADHD, the device received FDA approval in 2019.
Additionally, in March 2023, a hospital in Minneapolis recently opened the "first" pediatric hybrid intraoperative MRI neurosurgery unit in the country. The neurosciences programme and radiology division of Children's Minnesota utilise the 2,970 square foot Richard M Schulze Family Foundation iMRI Surgical Suite. Midway through operations to treat brain tumours, epilepsy, traumatic injuries, and more at the hospital in Minneapolis, specialists will do both brain and complete spine scans.
Parents and healthcare professionals are increasingly looking for enhanced diagnostic and therapeutic options as a result of growing awareness of pediatric neurological diseases and the value of early diagnosis. This rise in demand stimulates the creation of innovative pediatric-focused medical technology. Autism, cerebral palsy, and other pediatric neurological problems are becoming more prevalent around the world.
Market Dynamics: Restraint
Even though pediatric neurology devices have made significant progress, a number of constraints have made it difficult for them to be developed, adopted, and used effectively. For instance, progress may be hampered by a lack of funds and investment in the research and development of pediatric medical devices.
The small market size and high development costs for specialised devices may discourage investors and businesses from investing in this industry. Technical difficulties arise when building devices that are both efficient and secure for use in pediatric patients, whose bodies and physiological responses differ from adults.
Segment Analysis
The global pediatric neurology devices marketis segmented based on product type, application, age group, end-user and region.
The neurostimulation devices segment from the type segment accounted for approximately 41.7% of niemann-pick disease type share
Pediatric neurology is increasingly using neurostimulation devices to treat a variety of neurological problems and enhance the quality of life for kids with neurological disorders. By sending electrical impulses to particular nerves or regions of the brain, these devices modulate the aberrant neural activity linked to various illnesses. Due to its characteristics and the company's techniques used, the segment's growth is accelerated.
For instance, on Feburary 02, 2023, SenTiva DUO, an implantable pulse generator (IPG) with a dual-pin header, was introduced by LivaNova PLC to deliver VNS Therapy for the management of drug-resistant epilepsy. As an additional treatment for drug-resistant epilepsy in adults and children as young as 4 years old with partial onset seizures, VNS Therapy has been scientifically demonstrated to be both safe and effective. It is a advance method of care created for persons with drug-resistant epilepsy, a disorder that affects one in three epileptics. Thus, all of these factors support the segment's growth.
Geographical Analysis
North America accounted for approximately 38.4% of the market share in 2022
The growing prevalence of cerebral palsy, epilepsy, stroke, and other neurological conditions, as well as expanding research and development activities, rising investments, supporting governmental initiatives, and significant market players' key initiatives, are the main factors driving the growth of the North American pediatric neurology devices market.
During the period, it is anticipated that the United States will control a sizeable portion of the market in North America. For instance, more than 10,000 infants in the United States receive a cerebral palsy diagnosis each year, according to a Congress.gov account from March 2022. The need for these devices is rising as a result of the high frequency of cerebral palsy in the nation. Thus, all of those components aid in accelerating regional growth.
Moreover, Asia-Pacific is anticipated to have significant growth. This is because of the existence of high-population countries like China and India, which increases the probability that more people may suffer genetic disorders, as well as the expanding number of strategies and trends that market players are implementing.
COVID-19 Impact Analysis
Priorities for healthcare may change during a pandemic. The management of the COVID-19 patient influx may require reallocating resources, which may have an impact on the demand for non-essential medical devices, including some pediatric neurology products. Pandemics frequently occur during economic downturns. Budget restrictions may prevent hospitals and healthcare facilities from purchasing new medical equipment, especially pediatric neurology devices.
During a pandemic, the supply and production chains for medical devices might be severely interrupted. The availability of pediatric neurology devices may be impacted by transportation issues, factory closures, and restrictions on movement. Numerous neurological problems have been linked to COVID-19. Pediatric kids may require specialized neurology equipment to treat these symptoms because to the disease's long-term effects.
Market Segmentation
By Product Type
• Neurostimulation Devices
• Neurosurgery Devices
• Cerebrospinal Fluid (CSF) Management Devices
• Others
By Application
• Epilepsy Diagnosis and Management
• Cerebral Palsy Management
• Autism Spectrum Disorder (ASD) Management
• Genetic Neurological Disorders
• Others
By Age Group
• Infants
• Preschoolers
• Adolescents
By End-User
• Pediatric Hospitals
• Specialty Clinics
• Others
By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o UK
o France
o Italy
o Spain
o Rest of Europe
• South America
o Brazil
o Argentina
o Rest of South America
• Asia-Pacific
o China
o India
o Japan
o Australia
o Rest of Asia-Pacific
• Middle East and Africa
Competitive Landscape
The major global players in the market include Integra LifeSciences, Medtronic, Abbott Laboratories, B.Braun Melsungen, Philips Healthcare, LivaNova, Boston Scientific, Natus Medical, Masimo Corporation, Compumedics Limited and among others.
Key Developments
• On March 21, 2023, The Food and Drug Administration (FDA) granted Inspire Medical Systems, Inc. permission to provide Inspire therapy to pediatric patients with Down syndrome. Inspire Medical Systems, Inc. focuses on the development and commercialization of novel, minimally invasive solutions for patients with obstructive sleep apnea (OSA).
• In January 2023, a strategic digital marketing collaboration between Data360 and NeuroSigma, Inc., a Los Angeles-based bioelectronics business that markets external trigeminal nerve stimulation (eTNS) technology for the treatment of neurological and neuropsychiatric illnesses, had started. These initiatives will be supported by the relationship with Data360, which will make use of its innovative data platform with artificial intelligence (AI).
Why Purchase the Report?
• To visualize the global pediatric neurology devices market segmentation based on product type, application, age group, end-user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of pediatric neurology devices market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.
The global pediatric neurology devices market report would provide approximately 69 tables, 58 figures and 187 Pages.
Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

상세 목차

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Product Type
3.2. Snippet by Application
3.3. Snippet by Age Group
3.4. Snippet by End-User
3.5. Snippet by Region
4. Market Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. The strategies adopted by the companies
4.1.1.2. Rising the prevalence of neurological diseases
4.2. Restraints
4.2.1.1. The high costs associated with developing specialized devices
4.2.2. Opportunity
4.2.3. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Unmet Needs
5.6. DMI Opinion
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID
6.1.2. Scenario During COVID
6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Product Type
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
7.1.2. Market Attractiveness Index, By Product Type
7.2. Neurostimulation Devices *
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Neurosurgery Devices
7.4. Cerebrospinal Fluid (CSF) Management Devices
7.5. Others
8. By Application
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
8.1.2. Market Attractiveness Index, By Application
8.2. Epilepsy Diagnosis and Management *
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Cerebral Palsy Management
8.4. Autism Spectrum Disorder (ASD) Management
8.5. Genetic Neurological Disorders
8.6. Others
9. By Age Group
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
9.1.2. Market Attractiveness Index, By Age Group
9.2. Infants *
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Preschoolers
9.4. Adolescents
10. By End-User
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.1.2. Market Attractiveness Index, By End-User
10.2. Pediatric Hospitals *
10.2.1. Introduction
10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Specialty Clinics
10.4. Others
11. By Region
11.1. Introduction
11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
11.1.2. Market Attractiveness Index, By Region
11.2. North America
11.2.1. Introduction
11.2.2. Key Region-Specific Dynamics
11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.2.7.1. U.S.
11.2.7.2. Canada
11.2.7.3. Mexico
11.3. Europe
11.3.1. Introduction
11.3.2. Key Region-Specific Dynamics
11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.3.7.1. Germany
11.3.7.2. UK
11.3.7.3. France
11.3.7.4. Italy
11.3.7.5. Spain
11.3.7.6. Rest of Europe
11.4. South America
11.4.1. Introduction
11.4.2. Key Region-Specific Dynamics
11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.4.7.1. Brazil
11.4.7.2. Argentina
11.4.7.3. Rest of South America
11.5. Asia-Pacific
11.5.1. Introduction
11.5.2. Key Region-Specific Dynamics
11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.5.7.1. China
11.5.7.2. India
11.5.7.3. Japan
11.5.7.4. Australia
11.5.7.5. Rest of Asia-Pacific
11.6. Middle East and Africa
11.6.1. Introduction
11.6.2. Key Region-Specific Dynamics
11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
12. Competitive Landscape
12.1. Competitive Scenario
12.2. Market Positioning/Share Analysis
12.3. Mergers and Acquisitions Analysis
13. Company Profiles
13.1. Integra LifeSciences *
13.1.1. Company Overview
13.1.2. Product Portfolio and Description
13.1.3. Financial Overview
13.1.4. Key Developments
13.2. Medtronic Inc
13.3. Abbott Laboratories
13.4. B.Braun Melsungen
13.5. Philips Healthcare
13.6. LivaNova
13.7. Boston Scientific
13.8. Natus Medical
13.9. Masimo Corporation
13.10. Compumedics Limited
LIST NOT EXHAUSTIVE
14. Appendix
14.1. About Us and Services
14.2. Contact Us

언급된 주요 기업들

Integra LifeSciences, 4.	Key Developments, Medtronic Inc, Abbott Laboratories, B.Braun Melsungen, Philips Healthcare, LivaNova, Boston Scientific, Natus Medical, Masimo Corporation, Compumedics Limited

표 목록 (Tables)

List of Tables

Table 1 Global Pediatric Neurology Devices Market Value, By Product Type, 2022, 2026 & 2030 (US$ Million)

Table 2 Global Pediatric Neurology Devices Market Value, By Application, 2022, 2026 & 2030 (US$ Million)

Table 3 Global Pediatric Neurology Devices Market Value, By Age Group, 2022, 2026 & 2030 (US$ Million)

Table 4 Global Pediatric Neurology Devices Market Value, By End-User, 2022, 2026 & 2030 (US$ Million)

Table 5 Global Pediatric Neurology Devices Market Value, By Region, 2022, 2026 & 2030 (US$ Million)

Table 6 Global Pediatric Neurology Devices Market Value, By Product Type, 2022, 2026 & 2030 (US$ Million)

Table 7 Global Pediatric Neurology Devices Market Value, By Product Type, 2021-2030 (US$ Million)

Table 8 Global Pediatric Neurology Devices Market Value, By Application, 2022, 2026 & 2030 (US$ Million)

Table 9 Global Pediatric Neurology Devices Market Value, By Application, 2021-2030 (US$ Million)

Table 10 Global Pediatric Neurology Devices Market Value, By Age Group, 2022, 2026 & 2030 (US$ Million)

Table 11 Global Pediatric Neurology Devices Market Value, By Age Group, 2021-2030 (US$ Million)

Table 12 Global Pediatric Neurology Devices Market Value, By End-User, 2022, 2026 & 2030 (US$ Million)

Table 13 Global Pediatric Neurology Devices Market Value, By End-User, 2021-2030 (US$ Million)

Table 14 Global Pediatric Neurology Devices Market Value, By Region, 2022, 2026 & 2030 (US$ Million)

Table 15 Global Pediatric Neurology Devices Market Value, By Region, 2021-2030 (US$ Million)

Table 16 North America Pediatric Neurology Devices Market Value, By Product Type, 2021-2030 (US$ Million)

Table 17 North America Pediatric Neurology Devices Market Value, By Application, 2021-2030 (US$ Million)

Table 18 North America Pediatric Neurology Devices Market Value, By Age Group, 2021-2030 (US$ Million)

Table 19 North America Pediatric Neurology Devices Market Value, By End-User, 2021-2030 (US$ Million)

Table 20 North America Pediatric Neurology Devices Market Value, By Country, 2021-2030 (US$ Million)

Table 21 South America Pediatric Neurology Devices Market Value, By Product Type, 2021-2030 (US$ Million)

Table 22 South America Pediatric Neurology Devices Market Value, By Application, 2021-2030 (US$ Million)

Table 23 South America Pediatric Neurology Devices Market Value, By Age Group, 2021-2030 (US$ Million)

Table 24 South America Pediatric Neurology Devices Market Value, By End-User, 2021-2030 (US$ Million)

Table 25 South America Pediatric Neurology Devices Market Value, By Country, 2021-2030 (US$ Million)

Table 26 Europe Pediatric Neurology Devices Market Value, By Product Type, 2021-2030 (US$ Million)

Table 27 Europe Pediatric Neurology Devices Market Value, By Application, 2021-2030 (US$ Million)

Table 28 Europe Pediatric Neurology Devices Market Value, By Age Group, 2021-2030 (US$ Million)

Table 29 Europe Pediatric Neurology Devices Market Value, By End-User, 2021-2030 (US$ Million)

Table 30 Europe Pediatric Neurology Devices Market Value, By Country, 2021-2030 (US$ Million)

Table 31 Asia-Pacific Pediatric Neurology Devices Market Value, By Product Type, 2021-2030 (US$ Million)

Table 32 Asia-Pacific Pediatric Neurology Devices Market Value, By Application, 2021-2030 (US$ Million)

Table 33 Asia-Pacific Pediatric Neurology Devices Market Value, By Age Group, 2021-2030 (US$ Million)

Table 34 Asia-Pacific Pediatric Neurology Devices Market Value, By End-User, 2021-2030 (US$ Million)

Table 35 Asia-Pacific Pediatric Neurology Devices Market Value, By Country, 2021-2030 (US$ Million)

Table 36 Middle East & Africa Pediatric Neurology Devices Market Value, By Product Type, 2021-2030 (US$ Million)

Table 37 Middle East & Africa Pediatric Neurology Devices Market Value, By Application, 2021-2030 (US$ Million)

Table 38 Middle East & Africa Pediatric Neurology Devices Market Value, By Age Group, 2021-2030 (US$ Million)

Table 39 Middle East & Africa Pediatric Neurology Devices Market Value, By End-User, 2021-2030 (US$ Million)

Table 40 Integra LifeSciences: Overview

Table 41 Integra LifeSciences: Product Portfolio

Table 42 Integra LifeSciences: Key Developments

Table 43 Medtronic Inc: Overview

Table 44 Medtronic Inc: Product Portfolio

Table 45 Medtronic Inc: Key Developments

Table 46 Abbott Laboratories: Overview

Table 47 Abbott Laboratories: Product Portfolio

Table 48 Abbott Laboratories: Key Developments

Table 49 B.Braun Melsungen: Overview

Table 50 B.Braun Melsungen: Product Portfolio

Table 51 B.Braun Melsungen: Key Developments

Table 52 Philips Healthcare: Overview

Table 53 Philips Healthcare: Product Portfolio

Table 54 Philips Healthcare: Key Developments

Table 55 LivaNova: Overview

Table 56 LivaNova: Product Portfolio

Table 57 LivaNova: Key Developments

Table 58 Boston Scientific: Overview

Table 59 Boston Scientific: Product Portfolio

Table 60 Boston Scientific: Key Developments

Table 61 Natus Medical: Overview

Table 62 Natus Medical: Product Portfolio

Table 63 Natus Medical: Key Developments

Table 64 Masimo Corporation: Overview

Table 65 Masimo Corporation: Product Portfolio

Table 66 Masimo Corporation: Key Developments

Table 67 Compumedics Limited: Overview

Table 68 Compumedics Limited: Product Portfolio

Table 69 Compumedics Limited: Key Developments

그림 목록 (Figures)

List of Figures

Figure 1 Global Pediatric Neurology Devices Market Value, 2021-2030 (US$ Million)

Figure 2 Global Pediatric Neurology Devices Market Share, By Product Type, 2022 & 2030 (%)

Figure 3 Global Pediatric Neurology Devices Market Share, By Application, 2022 & 2030 (%)

Figure 4 Global Pediatric Neurology Devices Market Share, By Age Group, 2022 & 2030 (%)

Figure 5 Global Pediatric Neurology Devices Market Share, By End-User, 2022 & 2030 (%)

Figure 6 Global Pediatric Neurology Devices Market Share, By Region, 2022 & 2030 (%)

Figure 7 Global Pediatric Neurology Devices Market Y-o-Y Growth, By Product Type, 2022-2030 (%)

Figure 8 Neurostimulation Devices Pediatric Neurology Devices Market Value, 2021-2030 (US$ Million)

Figure 9 Neurosurgery Devices Pediatric Neurology Devices Market Value, 2021-2030 (US$ Million)

Figure 10 Cerebrospinal Fluid (CSF) Management Devices Pediatric Neurology Devices Market Value, 2021-2030 (US$ Million)

Figure 11 Others Pediatric Neurology Devices Market Value, 2021-2030 (US$ Million)

Figure 12 Global Pediatric Neurology Devices Market Y-o-Y Growth, By Application, 2022-2030 (%)

Figure 13 Epilepsy Diagnosis and Management Application in Global Pediatric Neurology Devices Market Value, 2021-2030 (US$ Million)

Figure 14 Cerebral Palsy Management Application in Global Pediatric Neurology Devices Market Value, 2021-2030 (US$ Million)

Figure 15 Autism Spectrum Disorder (ASD) Management Application in Global Pediatric Neurology Devices Market Value, 2021-2030 (US$ Million)

Figure 16 Genetic Neurological Disorders Application in Global Pediatric Neurology Devices Market Value, 2021-2030 (US$ Million)

Figure 17 Others Application in Global Pediatric Neurology Devices Market Value, 2021-2030 (US$ Million)

Figure 18 Global Pediatric Neurology Devices Market Y-o-Y Growth, By Age Group, 2022-2030 (%)

Figure 19 Infants Age Group in Global Pediatric Neurology Devices Market Value, 2021-2030 (US$ Million)

Figure 20 Preschoolers Age Group in Global Pediatric Neurology Devices Market Value, 2021-2030 (US$ Million)

Figure 21 Adolescents Age Group in Global Pediatric Neurology Devices Market Value, 2021-2030 (US$ Million)

Figure 22 Global Pediatric Neurology Devices Market Y-o-Y Growth, By End-User, 2022-2030 (%)

Figure 23 Pediatric Hospitals End-User in Global Pediatric Neurology Devices Market Value, 2021-2030 (US$ Million)

Figure 24 Specialty Clinics End-User in Global Pediatric Neurology Devices Market Value, 2021-2030 (US$ Million)

Figure 25 Others End-User in Global Pediatric Neurology Devices Market Value, 2021-2030 (US$ Million)

Figure 26 Global Pediatric Neurology Devices Market Y-o-Y Growth, By Region, 2022-2030 (%)

Figure 27 North America Pediatric Neurology Devices Market Value, 2021-2030 (US$ Million)

Figure 28 Asia-Pacific Pediatric Neurology Devices Market Value, 2021-2030 (US$ Million)

Figure 29 Europe Pediatric Neurology Devices Market Value, 2021-2030 (US$ Million)

Figure 30 South America Pediatric Neurology Devices Market Value, 2021-2030 (US$ Million)

Figure 31 Middle East and Africa Pediatric Neurology Devices Market Value, 2021-2030 (US$ Million)

Figure 32 North America Pediatric Neurology Devices Market Value, 2021-2030 (US$ Million)

Figure 33 North America Pediatric Neurology Devices Market Share, By Product Type, 2022 & 2030 (%)

Figure 34 North America Pediatric Neurology Devices Market Share, By Application, 2022 & 2030 (%)

Figure 35 North America Pediatric Neurology Devices Market Share, By Age Group, 2022 & 2030 (%)

Figure 36 North America Pediatric Neurology Devices Market Share, By End-User, 2022 & 2030 (%)

Figure 37 North America Pediatric Neurology Devices Market Share, By Country, 2022 & 2030 (%)

Figure 38 South America Pediatric Neurology Devices Market Value, 2021-2030 (US$ Million)

Figure 39 South America Pediatric Neurology Devices Market Share, By Product Type, 2022 & 2030 (%)

Figure 40 South America Pediatric Neurology Devices Market Share, By Application, 2022 & 2030 (%)

Figure 41 South America Pediatric Neurology Devices Market Share, By Age Group, 2022 & 2030 (%)

Figure 42 South America Pediatric Neurology Devices Market Share, By End-User, 2022 & 2030 (%)

Figure 43 South America Pediatric Neurology Devices Market Share, By Country, 2022 & 2030 (%)

Figure 44 Europe Pediatric Neurology Devices Market Value, 2021-2030 (US$ Million)

Figure 45 Europe Pediatric Neurology Devices Market Share, By Product Type, 2022 & 2030 (%)

Figure 46 Europe Pediatric Neurology Devices Market Share, By Application, 2022 & 2030 (%)

Figure 47 Europe Pediatric Neurology Devices Market Share, By Age Group, 2022 & 2030 (%)

Figure 48 Europe Pediatric Neurology Devices Market Share, By End-User, 2022 & 2030 (%)

Figure 49 Europe Pediatric Neurology Devices Market Share, By Country, 2022 & 2030 (%)

Figure 50 Asia-Pacific Pediatric Neurology Devices Market Value, 2021-2030 (US$ Million)

Figure 51 Asia-Pacific Pediatric Neurology Devices Market Share, By Product Type, 2022 & 2030 (%)

Figure 52 Asia-Pacific Pediatric Neurology Devices Market Share, By Application, 2022 & 2030 (%)

Figure 53 Asia-Pacific Pediatric Neurology Devices Market Share, By Age Group, 2022 & 2030 (%)

Figure 54 Asia-Pacific Pediatric Neurology Devices Market Share, By End-User, 2022 & 2030 (%)

Figure 55 Asia-Pacific Pediatric Neurology Devices Market Share, By Country, 2022 & 2030 (%)

Figure 56 Middle East & Africa Pediatric Neurology Devices Market Value, 2021-2030 (US$ Million)

Figure 57 Middle East & Africa Pediatric Neurology Devices Market Share, By Product Type, 2022 & 2030 (%)

Figure 58 Middle East & Africa Pediatric Neurology Devices Market Share, By Application, 2022 & 2030 (%)

Figure 59 Middle East & Africa Pediatric Neurology Devices Market Share, By Age Group, 2022 & 2030 (%)

Figure 60 Middle East & Africa Pediatric Neurology Devices Market Share, By End-User, 2022 & 2030 (%)

Figure 61 Integra LifeSciences: Financials

Figure 62 Medtronic Inc: Financials

Figure 63 Abbott Laboratories: Financials

Figure 64 B.Braun Melsungen: Financials

Figure 65 Philips Healthcare: Financials

Figure 66 LivaNova: Financials

Figure 67 Boston Scientific: Financials

Figure 68 Natus Medical: Financials

Figure 69 Masimo Corporation: Financials

Figure 70 Compumedics Limited: Financials

글로벌 소아 신경과 의료기기 시장 – 2023-2030

Global Pediatric Neurology Devices Market - 2023-2030